A Secret Weapon For new active pharmaceutical ingredients
In the exact same calendar year the ITC also described on their endeavours to the flow syntheses of two direct compounds reported previously by AstraZeneca. The first one specifics the move synthesis of a strong 5HT1B antagonist (28) which was assembled via a five action steady synthesis such as a S